ERBB2 and neoplasm: As identified in our study, patient characteristics including elder age and more comorbidities, surgical factor like BCS procedure, as well as tumor factors like non-IDC histologic type, and HER2-positive subtype were significantly associated with chemotherapy initiation delay.